1776 Wealth’s Elevance Health ELV Stock Holding History

1776 Wealth’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-124	Closed	-$32K	–	166
2020 Q2	$32K	Buy	124 +74	+148%	+$19.7K	0.02%	216
2020 Q1	$11K	Hold	50	–	–	0.01%	263
2019 Q4	$15K	Buy	+50	New	+$13.8K	0.01%	249

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

1776 Wealth's ELV Position: Q3 2020 in Review

1776 Wealth sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 124 shares — an estimated $32K sold.

1776 Wealth first reported a position in ELV in Q4 2019 and held it in 3 quarters. The position peaked at $32K in Q2 2020. 1,095 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

1776 Wealth reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
1776 Wealth sold 124 Elevance Health shares in Q3 2020, an estimated $32K.
1776 Wealth first reported a position in Elevance Health in Q4 2019 and held it in 3 quarters.
1776 Wealth's Elevance Health position peaked at $32K in Q2 2020.
1,095 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.